USPTO serial 79252467
APTASIGN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 29, 2020
- Examiner
- BELZER, LYDIA M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with APTASIGN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $1,275
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kisuk Lee
Kisuk Lee Harness, Dickey & Pierce, PLC7700 Bonhomme Ave, Suite 400St. Louis, MO 63105UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical diagnostic reagents for immunization from disease; diagnostic test reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; preparations for detecting genetic predispositions for medical purposes; diagnostic preparations for medical purposes for detecting genetic predispositions; reagents for use in medical genetic testing; in vitro diagnostic preparations for medical purposes; clinical diagnostic reagents for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis for medical or veterinary purposes; reagents for use in veterinary genetic testing; antibodies for medical purposes; aptamers for medical purposes; diagnostic antibodies for medical purposes; diagnostic aptamers for medical purposes | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical apparatus and instruments other than for dental purposes, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; apparatus for use in medical analysis, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical genetic testing devices, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical instruments in the nature of genetic fragment analyzers; medical instruments in the nature of genetic material analyzers; medical absorption analysis apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; DNA extraction and purification apparatus for medical purposes; medical apparatus and instruments in the fields of clinical diagnostics, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; body composition analyzers for medical purposes; body fluid analysis apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; in vitro diagnostic devices, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical apparatus and instruments for DNA analysis, other than for dental purposes; medical apparatus and instruments for RNA analysis, other than for dental purposes; medical apparatus and instruments for protein analysis, other than for dental purposes; gene and genetic testing apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; cancer diagnosis apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; diagnostic apparatus for medical purposes, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical body composition monitor; medical apparatus and instruments in the fields of clinical diagnostics, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; immunoassay apparatus for diagnostics, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; miniaturized sensors for medical use in gene analysis and diagnosis; veterinary apparatus and instruments for DNA analysis; veterinary apparatus and instruments for RNA analysis; veterinary apparatus and instruments for protein analysis | ACTIVE | — |
| 044 | Medical and healthcare services relating to DNA and genetics analysis and diagnosis and genetic testing; medical analysis services relating to the treatment of persons; physical examination services; medical services relating to the removal, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow; medical analysis for the diagnosis and treatment of persons; RNA or DNA analysis for cancer diagnosis and prognosis; medical analysis services for cancer diagnosis and prognosis; genetic testing for medical purposes; provision of genetic testing for medical treatment purposes; provision of genetic information for medical treatment purposes; medical examination services; rental of medical machines and apparatus; rental of medical apparatus; performing medical diagnostic services involving medical testing and analysis for diagnostic and treatment purposes; medical testing services relating to the diagnosis and treatment of disease; Medical analysis services for the analysis of blood samples for diagnostic and treatment purposes provided by a medical laboratory; Medical analysis services for the analysis of samples taken from patients for diagnostic and treatment purposes provided by a medical laboratory; Medical analysis services for the analysis of blood samples taken from patients for diagnostic and treatment purposes provided by a medical laboratory | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIOIS Co., Ltd
- Other trademarks owned by BIOIS Co., Ltd
- Other trademarks owned by BIOIS Co., Ltd
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named APTASIGN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 29, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 6, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 15, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 15, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 29, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 29, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 7, 2020 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 22, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 22, 2020 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 14, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 14, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 24, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 10, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 28, 2019 | LOPR | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | — |
| Oct 17, 2019 | LOPT | LETTER OF PROTEST EVIDENCE FORWARDED | — |
| Sep 25, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 24, 2019 | ALIE | ASSIGNED TO LIE | — |
| Sep 24, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 24, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 24, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 14, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 13, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 13, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 26, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 26, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 12, 2019 | RFNP | REFUSAL PROCESSED BY IB | — |
| Mar 28, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 28, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 20, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 19, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 8, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 2, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 26, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 21, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |